CClinicalTrials.gg
CompletedNCT05335798Updated Nov 20, 2025

Reinforcing CP Robotic Training With Auditory Feedback

An interventional study of Bodyweight augment system and Smart insole in Cerebral Palsy, sponsored by State University of New York at Buffalo. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-11-20.

Sponsored by State University of New York at Buffalo · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Dec 2021, registered Mar 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to create a platform to prolong the adaption obtained from the cable-actuated gait training and encourage the individuals with CP to provide self-care at home.

Read the detailed description

The experiment protocol involves a maximum of ten sessions and will take two or three hours for each session. Baseline data will be collected before the first session for both overground and treadmill walking. During this session, the sound level will be adjusted based on the feedback received from the users. The researcher will ask the comfortable sound level to the participant before starting the experiment. Training will be conducted on the treadmill with the cable-actuated device for about 20 minutes. When the cables were removed, participants walked on the treadmill for 4 minutes during the post-training session. During training and post-training, participants will be exposed to feedback while walking on the treadmill. After treadmill walking, CP participants will be asked to take a ten-minute break and then practice overground walking for two minutes with auditory feedback (type A) and without it (type B). Effects of 3 different types of auditory feedback will be explored namely, rhythmic sounds, movement sonification, and sound notifying erroneous gait. Group A participants will be further divided into groups depending on the type of auditory feedback that will be provided. Participants will participate in a maximum of 10 sessions, two or three times a week. Before the first and after the last training, participants will be evaluated for functional gait assessment, 6-min-walk, leg strength using a dynamometer, and Modified Ashworth test by a physical therapist.

02

Conditions studied

  • Cerebral Palsy

Browse trials for

03

In context

Cerebral Palsy

1,853 studies on the registry are indexed under Cerebral Palsy; 433 are open to participants now.

This study's enrollment of 5 is below the median of 33 across 1,368 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

State University of New York at Buffalo is the lead sponsor of 287 studies on the registry; 65 are open to participants now.

Of its 19 completed or terminated interventional studies of FDA-regulated products, 15 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults with cerebral palsy (18-65 years old)
  • Ambulation of a distance of 100 feet with or without the use of assistive devices.

Exclusion criteria

Exclusion Criteria:

  • Severe Equinovarus foot or Genu recurvatum of the knee
  • Surgery within 6 months will be excluded.
  • Individuals with pregnancy
  • Lower limb prosthetics
  • Severe respiratory problems such as chronic obstructive pulmonary disease, heart disease, a loss of sensation, uncontrolled blood pressure,
  • Seizure disorder
  • Severe arthritis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    Adults with Cerebral Palsy

    Adults with Cerebral Palsy who are able to be self-ambulatory for minimum 100 feet

    Device: Bodyweight augment system · Device: Smart insole

Interventions

  • DeviceBodyweight augment system

    Motorized cables will be providing downward force on the participant's pelvis

  • DeviceSmart insole

    Insole provided auditory feedback when heel strike or toe-off events happen

06

What researchers measure

Primary outcomes

  1. Change of 10m walk between pre/post evaluation and 6 Training sessions

    Timing in seconds during 10 m over ground walking. Lower score means faster (better) walking speed

    Time frame: through study completion, an average of 5 weeks

  2. Change of 6 min walk between Pre/post evaluation

    Measure distance in meter over 6 min walk. Increased distance shows better walking endurance

    Time frame: through study completion, an average of 5 weeks

  3. Change of Ground reaction force between 6 Training sessions

    Bertec Force instrumented treadmill will use to measure vertical ground reaction force in Newton. We will identify whether we can see a distict heel strike and strong push

    Time frame: through study completion, an average of 5 weeks

  4. Change of Kinematics between Pre/post evaluation and 6 Training sessions

    Motion capture data. We will measure hip, knee, and ankle joint angles in degrees. We expect to see If the knees is more extended and dorsiflexion is observed at heel strike the gait is improved

    Time frame: through study completion, an average of 5 weeks

  5. Change of surface electromyography between Pre/post evaluation and 6 Training sessions

    Surface electromyography will be measured for the lower limb. Unit is in mV. We are expecting to measure the peak semg during each gait cycle.

    Time frame: through study completion, an average of 5 weeks

Other outcomes

  1. Change of Muscle tone between Pre/post evaluation

    Modified Ashworth Scale a clinical measure of muscle spasticity. Rated from 0(no increase in muscle tone) to 4(affected part rigid in flexion or extension). Lower score means better muscle tone.

    Time frame: through study completion, an average of 5 weeks

  2. Usability questionnaire of Post evaluation

    Questionnaires were made to understand the the perceived improvement (increased steps and walking speed ) or dose of the intervention (more session and frequency of the intervention). It is rated from 1 very likely to 5 unlikely.

    Time frame: through study completion, an average of 5 weeks

  3. Exit interview after completion of the sessions of Post evaluation

    This is designed for any improvement of future study design. We will ask questions on potential improvement of the intervention

    Time frame: through study completion, an average of 5 weeks

  4. Change of strength of Post evaluation between Pre/post evaluation

    Measure the strength with Dynamometer in N. Higher number means stronger limb.

    Time frame: through study completion, an average of 5 weeks

  5. Change of functional gait assessment between Pre/post evaluation

    Measure different aspects of gait. It is rated from 0 to 3. Higher score means improved improved walking during gait with level surface, change in speed, gait with head turns, step over obstacle, gait with eyes closed, steps.

    Time frame: through study completion, an average of 5 weeks

07

Study locations

1 site
  • University at Buffalo, South Campus, Kimball 115
    Buffalo, New York 14260-4200, United States
08

References and documents

Publications

  • Chen D, Asaeikheybari G, Chen H, Xu W, Huang MC. Ubiquitous Fall Hazard Identification With Smart Insole. IEEE J Biomed Health Inform. 2021 Jul;25(7):2768-2776. doi: 10.1109/JBHI.2020.3046701. Epub 2021 Jul 27. PubMed 33351772 ↗
  • Kang J, Martelli D, Vashista V, Martinez-Hernandez I, Kim H, Agrawal SK. Robot-driven downward pelvic pull to improve crouch gait in children with cerebral palsy. Sci Robot. 2017 Jul 26;2(8):eaan2634. doi: 10.1126/scirobotics.aan2634. Epub 2017 Jul 26. PubMed 33157884 ↗

Study documents

  • Protocol and statistical analysis plan · Mar 7, 2022
  • Informed consent form · Mar 7, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — The de-identified data will be shared upon request to PI.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05335798
Lead sponsor
State University of New York at Buffalo
Responsible party
Jiyeon Kang (Assistant Professor, State University of New York at Buffalo) — Principal investigator
First posted
Apr 19, 2022
Start date
Dec 7, 2021
Primary completion
Dec 5, 2024
Completion
Dec 7, 2024
Last update
Nov 20, 2025

Study contacts

Jiyeon Kang
principal investigator · University at Buffalo

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion